Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
APH compared with ABT: revenue, margins and what each company keeps, and the suppliers and customers both name
APH
Amphenol Corp
Change
Mkt cap
Revenue
Revenue
ABT
Abbott Laboratories
Change
Mkt cap
Revenue
Revenue
vs
Compare
APH
Amphenol Corp
vs
ABT
Abbott Laboratories
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
APH
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±9.3%
▲
+3.52%
×0.38
Q2 FY26
±11.8%
▲
+4.49%
×0.38
Q1 FY26
±9.6%
▲
+3.24%
×0.33
Jan 28 '26
±8.5%
▼
−12.20%
×1.44
ABT
3 of 4
at or beyond implied
Report
implied
realized
× implied
Oct 21 '26
±5.3%
▼
−1.89%
×0.36
Q2 FY26
±4.3%
▲
+10.71%
×2.49
= implied
APH realized, solid
ABT realized, hatched
One scale, both sides: full bar = 13%
× = |realized| ÷ implied
Source: market data
Q1 FY26
±4.4%
▼
−6.00%
×1.36
Jan 22 '26
±3.2%
▼
−10.04%
×3.13
APH
Amphenol Corp
Change
79.31
▼
−3.37%
· post 79.42
Mkt cap
$195.8B
Revenue
$10.2B
Q3 FY26
Revenue
$23.1B
FY25
ABT
Abbott Laboratories
Change
106.21
▲
+1.57%
· post 106.18
Closed
Oct 30 '26
Mkt cap
$183.8B
Revenue
$12.6B
Q2 FY26
Revenue
$44.3B
FY25
vs
Compare
Closed
Oct 30 '26
APH
Amphenol Corp
vs
ABT
Abbott Laboratories
79.31
▼
−3.37%
post 79.42
Price
106.21
▲
+1.57%
post 106.18
$195.8B
Mkt cap
$183.8B
Q3 FY26
$10.2B
Revenue
$12.6B
Q2 FY26
FY25
$23.1B
Revenue
$44.3B
FY25
Change
Change
APH
79.31
▼
−3.37%
vs
ABT
106.21
▲
+1.57%
Closed
Oct 30 '26